VolitionRX Ltd (AMEX:VNRX)
$ 0.695101 -0.024899 (-3.46%) Market Cap: 57.57 Mil Enterprise Value: 53.41 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

VolitionRX Ltd at OTC Markets Life Science Investor Forum (Virtual) Transcript

Mar 09, 2023 / 02:30PM GMT
Release Date Price: $1.9 (-6.40%)
John Viglotti
OTC Markets Group - SVP, Corporate Services

Hello, and welcome to Virtual Investor Conferences. My name is John Viglotti, and on behalf of OTC markets, we're very pleased you joined us for our Life Sciences Conference. Our first presentation comes from VolitionRx. And before I introduce our speaker, a few points to note. (Conference Instructions) On a final note, all of today's presentations will be recorded and available for 24/7 replay.

At this point, I'm very pleased to welcome Scott Powell. He's Head of Investor Relations and the US Chief Financial Officer of VolitionRx which trades on the NYSE American under the symbol VNRX.

Welcome back, Scott.

Scott Powell
VolitionRx Limited - VP of IR and CFO, Volition America, Inc.

Thank you, John. Thanks to virtualinvestorconferences.com and the OTC Markets. It's great to be back again presenting the VolitionRx story. So again, thank you for having us back again. As mentioned, we're VolitionRx, ticker VNRX on the NYSE American stock exchange.

I just want to point you to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot